Thomas Jackisch
Dresden University of Technology
11 Papers
59 Citations
Thomas Jackisch is an academic researcher from Dresden University of Technology. The author has contributed to research in topics: Medicine & Total mesorectal excision. The author has an hindex of 6, co-authored 9 publications.
Chat about Author
Papers
Outcome of bowel function following anterior resection for rectal cancer-an analysis using the low anterior resection syndrome (LARS) score.
Juliane Kupsch,Thomas Jackisch,Klaus E. Matzel,Joerg Zimmer,Andreas Schreiber,Anja Sims,Helmut Witzigmann,Sigmar Stelzner +7 more
TL;DR: The LARS score identified a substantial proportion of patients after surgery for rectal cancer with anorectal dysfunction, and the extent of surgical procedure is independently associated with the severity of symptoms whereas the role of radiotherapy needs further assessment.
79
Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades
Joern Fischer,Gunter Hellmich,Thomas Jackisch,Erik Puffer,Jörg Zimmer,Dorothea Bleyl,Thomas Kittner,Helmut Witzigmann,Sigmar Stelzner +8 more
TL;DR: This study aimed to investigate the outcome for stage II and III rectal cancer patients compared to stage Two and III colonic cancer patients with regard to 5-year cause-specific survival (CSS), overall survival, and local and combined recurrence rates over time.
Total fistulectomy with simple closure of the internal opening in the management of complex cryptoglandular fistulas: long-term results and functional outcome.
TL;DR: Total fistulectomy with simple closure of the internal opening is effective for the long-term closure of complex cryptoglandular fistulas and may affect continence despite its sphincter-sparing quality.
20
Practicability of quality goals for the treatment of rectal cancer
Sigmar Stelzner,Gunter Hellmich,Gunter Haroske,Erik Puffer,Thomas Jackisch,Helmut Witzigmann +5 more
TL;DR: Most of the defined quality goals can be achieved in a specialized coloproctologic unit, and the debate on quality goals has the potential to enable further improvement in the care of rectal cancer patients.
11
Selective surgical treatment of patients with rectal carcinoma and unresectable synchronous metastases based on response to preoperative chemotherapy.
TL;DR: Chemotherapy and response-dependent resection of the primary tumor results in the same survival time as that attained with immediate surgery, and patients who face a poor prognosis due to progressive disease are spared the risks of major rectal surgery.
10